‰ªŽR‘åŠw–@Šw‰ï
Acta Medica Okayama
0386-3050
75
2
2025
— •\Ž†E‰p•¶–ÚŽŸ
EN
No potential conflict of interest relevant to this article was reported.
‰ªŽR‘åŠw–@Šw‰ï
Acta Medica Okayama
0386-3050
75
2
2025
‰œ•t
EN
No potential conflict of interest relevant to this article was reported.
‰ªŽR‘åŠw–@Šw‰ï
Acta Medica Okayama
0386-3050
75
2
2025
–{†Ž·•MŽÒЉî
347
347
EN
No potential conflict of interest relevant to this article was reported.
‰ªŽR‘åŠw–@Šw‰ï
Acta Medica Okayama
0386-3050
75
2
2025
•ÛØ–±‹y‚јA‘Ñ–±E˜A‘ÑÂŒ ‚ÉŠÖ‚·‚éˆêlŽ@ ⑴ \ ‰ˆŠv“IE”äŠr–@“IlŽ@iƒ[ƒ}–@EDomatj \
114
87
EN
H.
Tsuji
No potential conflict of interest relevant to this article was reported.
‰ªŽR‘åŠw–@Šw‰ï
Acta Medica Okayama
0386-3050
75
2
2025
Paul Oertmann ‚ÌVorteilsausgleichung ‚Æ‘¹Ž¸•âž
140
115
EN
K.
Hamaguchi
No potential conflict of interest relevant to this article was reported.
‰ªŽR‘åŠw–@Šw‰ï
Acta Medica Okayama
0386-3050
75
2
2025
E‹Æ‘I‘ð‚ÌŽ©—R‚ÉŠÖ‚·‚é”»—á–@—
346
141
EN
T.
Ito
No potential conflict of interest relevant to this article was reported.
‰ªŽR‘åŠw–@Šw‰ï
Acta Medica Okayama
0386-3050
75
2
2025
•\Ž†E–ÚŽŸ
EN
No potential conflict of interest relevant to this article was reported.